175 related articles for article (PubMed ID: 1470280)
1. Liver disease in cystic fibrosis.
Colombo C; Apostolo MG; Assaisso M; Roman B; Bottani P
Neth J Med; 1992 Oct; 41(3-4):119-22. PubMed ID: 1470280
[TBL] [Abstract][Full Text] [Related]
2. Liver disease in children with cystic fibrosis.
Diwakar V; Pearson L; Beath S
Paediatr Respir Rev; 2001 Dec; 2(4):340-9. PubMed ID: 12052306
[TBL] [Abstract][Full Text] [Related]
3. Serum bile acids and ursodeoxycholic acid treatment in cystic fibrosis-related liver disease.
O'Brien SM; Campbell GR; Burke AF; Maguire OC; Rowlands BJ; FitzGerald MX; Hegarty JE
Eur J Gastroenterol Hepatol; 1996 May; 8(5):477-83. PubMed ID: 8804877
[TBL] [Abstract][Full Text] [Related]
4. A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease.
Lindblad A; Glaumann H; Strandvik B
Hepatology; 1998 Jan; 27(1):166-74. PubMed ID: 9425933
[TBL] [Abstract][Full Text] [Related]
5. Hepatobiliary disease in cystic fibrosis patients with pancreatic sufficiency.
Waters DL; Dorney SF; Gruca MA; Martin HC; Howman-Giles R; Kan AE; De Silva M; Gaskin KJ
Hepatology; 1995 Apr; 21(4):963-9. PubMed ID: 7535738
[TBL] [Abstract][Full Text] [Related]
6. Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis.
Smith JL; Lewindon PJ; Hoskins AC; Pereira TN; Setchell KD; O'Connell NC; Shepherd RW; Ramm GA
Hepatology; 2004 Jun; 39(6):1673-82. PubMed ID: 15185309
[TBL] [Abstract][Full Text] [Related]
7. Cholangiocyte biology and cystic fibrosis liver disease.
Feranchak AP; Sokol RJ
Semin Liver Dis; 2001 Nov; 21(4):471-88. PubMed ID: 11745036
[TBL] [Abstract][Full Text] [Related]
8. Liver disease in cystic fibrosis.
Colombo C
Curr Opin Pulm Med; 2007 Nov; 13(6):529-36. PubMed ID: 17901760
[TBL] [Abstract][Full Text] [Related]
9. Cystic fibrosis-associated liver disease.
Herrmann U; Dockter G; Lammert F
Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):585-92. PubMed ID: 20955961
[TBL] [Abstract][Full Text] [Related]
10. Long-term prospective study of the effect of ursodeoxycholic acid on cystic fibrosis-related liver disease.
Nousia-Arvanitakis S; Fotoulaki M; Economou H; Xefteri M; Galli-Tsinopoulou A
J Clin Gastroenterol; 2001 Apr; 32(4):324-8. PubMed ID: 11276276
[TBL] [Abstract][Full Text] [Related]
11. Hepatobiliary manifestations of cystic fibrosis.
Colombo C; Battezzati PM
Eur J Gastroenterol Hepatol; 1996 Aug; 8(8):748-54. PubMed ID: 8864670
[TBL] [Abstract][Full Text] [Related]
12. The benign course of liver disease in adults with cystic fibrosis and the effect of ursodeoxycholic acid.
Desmond CP; Wilson J; Bailey M; Clark D; Roberts SK
Liver Int; 2007 Dec; 27(10):1402-8. PubMed ID: 18036103
[TBL] [Abstract][Full Text] [Related]
13. Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis.
Colombo C; Battezzati PM; Podda M; Bettinardi N; Giunta A
Hepatology; 1996 Jun; 23(6):1484-90. PubMed ID: 8675168
[TBL] [Abstract][Full Text] [Related]
14. Liver disease in cystic fibrosis.
Colombo C; Russo MC; Zazzeron L; Romano G
J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S49-55. PubMed ID: 16819402
[TBL] [Abstract][Full Text] [Related]
15. Hepatobiliary disease in patients with cystic fibrosis.
Moyer K; Balistreri W
Curr Opin Gastroenterol; 2009 May; 25(3):272-8. PubMed ID: 19381084
[TBL] [Abstract][Full Text] [Related]
16. The current status of ursodeoxycholate in the treatment of chronic cholestatic liver disease.
Luketic VA; Sanyal AJ
Gastroenterologist; 1994 Mar; 2(1):74-9. PubMed ID: 8055235
[TBL] [Abstract][Full Text] [Related]
17. A single centre experience of liver disease in adults with cystic fibrosis 1995-2006.
Nash KL; Allison ME; McKeon D; Lomas DJ; Haworth CS; Bilton D; Alexander GJ
J Cyst Fibros; 2008 May; 7(3):252-7. PubMed ID: 18042441
[TBL] [Abstract][Full Text] [Related]
18. [Cystic fibrosis associated with liver disease].
Debray D
Arch Pediatr; 2012 May; 19 Suppl 1():S23-6. PubMed ID: 22682485
[TBL] [Abstract][Full Text] [Related]
19. Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease.
Debray D; Kelly D; Houwen R; Strandvik B; Colombo C
J Cyst Fibros; 2011 Jun; 10 Suppl 2():S29-36. PubMed ID: 21658639
[TBL] [Abstract][Full Text] [Related]
20. [Gastrointestinal complications of adult patients with cystic fibrosis].
Bargon J; Stein J; Dietrich CF; Müller U; Caspary WF; Wagner TO
Z Gastroenterol; 1999 Aug; 37(8):739-49. PubMed ID: 10494610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
